Studies have found that in Alzheimer's disease (AD), degeneration of the central cholinergic system and free radical metabolism are gradually aggravated, and the activities of SOD and GPx in hippocampus, which are closely related to the system, are significantly decreased over time (Pocernich & Butterfield, 2012). This evidence concerns the gene SOD1 and Alzheimer disease.